1. Home
  2. MRUS vs NBIS Comparison

MRUS vs NBIS Comparison

Compare MRUS & NBIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRUS
  • NBIS
  • Stock Information
  • Founded
  • MRUS 2003
  • NBIS 2000
  • Country
  • MRUS Netherlands
  • NBIS Netherlands
  • Employees
  • MRUS N/A
  • NBIS N/A
  • Industry
  • MRUS Biotechnology: Pharmaceutical Preparations
  • NBIS
  • Sector
  • MRUS Health Care
  • NBIS
  • Exchange
  • MRUS Nasdaq
  • NBIS NYSE
  • Market Cap
  • MRUS 4.1B
  • NBIS 4.8B
  • IPO Year
  • MRUS 2016
  • NBIS 2011
  • Fundamental
  • Price
  • MRUS $52.90
  • NBIS $54.47
  • Analyst Decision
  • MRUS Strong Buy
  • NBIS Strong Buy
  • Analyst Count
  • MRUS 12
  • NBIS 3
  • Target Price
  • MRUS $87.92
  • NBIS $60.67
  • AVG Volume (30 Days)
  • MRUS 1.2M
  • NBIS 17.3M
  • Earning Date
  • MRUS 07-31-2025
  • NBIS 07-30-2025
  • Dividend Yield
  • MRUS N/A
  • NBIS N/A
  • EPS Growth
  • MRUS N/A
  • NBIS N/A
  • EPS
  • MRUS N/A
  • NBIS N/A
  • Revenue
  • MRUS $54,732,000.00
  • NBIS $161,400,000.00
  • Revenue This Year
  • MRUS $75.57
  • NBIS $38,469.36
  • Revenue Next Year
  • MRUS $31.84
  • NBIS $106.37
  • P/E Ratio
  • MRUS N/A
  • NBIS N/A
  • Revenue Growth
  • MRUS 42.77
  • NBIS N/A
  • 52 Week Low
  • MRUS $33.19
  • NBIS $14.09
  • 52 Week High
  • MRUS $62.98
  • NBIS $55.75
  • Technical
  • Relative Strength Index (RSI)
  • MRUS 54.86
  • NBIS N/A
  • Support Level
  • MRUS $52.53
  • NBIS N/A
  • Resistance Level
  • MRUS $54.81
  • NBIS N/A
  • Average True Range (ATR)
  • MRUS 1.70
  • NBIS 0.00
  • MACD
  • MRUS -0.55
  • NBIS 0.00
  • Stochastic Oscillator
  • MRUS 39.04
  • NBIS 0.00

About MRUS Merus N.V.

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

About NBIS NEBIUS GROUP N V

Nebius Group NV is a tech company. It is a European provider of infrastructure and services to AI builders globally. The group builds full-stack infrastructure to service the growth of the AI industry, including the scale of GPU clusters, cloud platforms, tools, and services for developers. It has R&D hubs across Europe, North America and Israel.

Share on Social Networks: